Has anyone else seeing the announcement by the FDA on anti-TNF drugs relating to fungal infections? It certainly is not affecting the share price of arana negatively. The fact that art 621 is a small compound may read the news is a positive for the trial going forward. I am no expert in the field and am just putting the idea out for comment so all comments are welcome
- Forums
- ASX - By Stock
- AAH
- fda
AAH
arana therapeutics limited
fda
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AAH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online